郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).

期刊:Journal of medicinal chemistry发表年份:2010作者:Jun Li; Lawrence J Kennedy; Yan Shi; Shiwei Tao; Xiang-Yang Ye; Stephanie Y Chen; Ying Wang; Andrés S Hernández; Wei Wang; Pratik V Devasthale; Sean Chen; Zhi Lai; Hao Zhang; Shung Wu; Rebecca A Smirk; Scott A Bolton; Denis E Ryono; Huiping Zhang; Ng

药效评价Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.

期刊:Journal of medicinal chemistry发表年份:2010作者:Rajeshwar Narlawar; J Robert Lane; Munikumar Doddareddy; Judy Lin; Johannes Brussee; Adriaan P Ijzerman

药效评价RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo.

期刊:Journal of the American College of Cardiology发表年份:2010作者:Dana Bailey; Ravi Jahagirdar; Allan Gordon; Anouar Hafiane; Steven Campbell; Safia Chatur; Gregory S Wagner; Henrik C Hansen; Fabrizio S Chiacchia; Jan Johansson; Larbi Krimbou; Norman C W Wong; Jacques Genest

药效评价Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist.

期刊:Neuroscience发表年份:2010作者:M Picard; S Morisset; J F Cloix; J C Bizot; M Guerin; V Beneteau; G Guillaumet; T K Hevor